$ Value
$0
Shares
18,050
Price
$0
Filed
Jun 30
Insider
Name
Hoppenot Herve
Title
Special Advisor to the CEO
CIK
0001596492
Roles
Transaction Details
Transaction Date
2025-06-26
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
18,050
Footnotes
Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including the June 26, 2025 grant, this includes an aggregate of 187,611 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. | The June 26, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. | Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ('TSR') over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date.
Filing Info
Hoppenot Herve's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-08 | BCYC | A | $0 |
| 2025-09-08 | BCYC | A | $0 |
| 2025-07-15 | INCY | F | $322K |
| 2025-07-14 | INCY | F | $347K |
| 2025-07-02 | INCY | F | $2.9M |
| 2025-06-26 | INCY | A | $0 |
| 2025-06-26 | INCY | A | $0 |
| 2025-06-26 | INCY | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |